By Femtech Insider Breast Health, News, Women's Health June 9, 2021 ShareTwitterFacebookPinterest-circled Agendia’s MammaPrint Spots Ultra-Low Breast Cancer Recurrence Risks Helping Identify Women Who Could Skip Chemo
By Femtech Insider Acquisition, Breast Health, News, Oncology, Uncategorized April 22, 2021 ShareTwitterFacebookPinterest-circled Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test
By Femtech Insider Breast Health, News, Oncology March 23, 2021 ShareTwitterFacebookPinterest-circled The Breast Cancer Alliance Celebrates Its 25th Anniversary
By Femtech Insider Breast Health, News, Oncology, Women's Health February 24, 2021 ShareTwitterFacebookPinterest-circled Hologic Completes Acquisition of Biotheranostics, Enabling Entry into Growing Oncology Market
By Femtech Insider Breast Health, Reports, Research February 22, 2021 ShareTwitterFacebookPinterest-circled New Research Confirms Black Women Are More Likely to Receive Inferior Breast Cancer Screening Than White Women
By Femtech Insider Biotech, Breast Health, Career, Oncology, Women's Health February 7, 2021 ShareTwitterFacebookPinterest-circled Veteran Biotech Executive Elizabeth Cormier-May Joins Women’s Health Startup Mammogen as the Company’s New CEO
By Femtech Insider Breast Health, Investment, News, Oncology January 12, 2021 ShareTwitterFacebookPinterest-circled BioAesthetics Announces a $5M Series A to Commercialize NACgraft, a Regenerative Nipple Graft for Breast Cancer Survivors
By Femtech Insider Breast Health, Exit, News, Oncology January 5, 2021 ShareTwitterFacebookPinterest-circled Hologic to Acquire Biotheranostics, a Leader in Molecular Tests for Breast and Metastatic Cancers
